UniProt ID | RHG01_HUMAN | |
---|---|---|
UniProt AC | Q07960 | |
Protein Name | Rho GTPase-activating protein 1 | |
Gene Name | ARHGAP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 439 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | GTPase activator for the Rho, Rac and Cdc42 proteins, converting them to the putatively inactive GDP-bound state. Cdc42 seems to be the preferred substrate.. | |
Protein Sequence | MDPLSELQDDLTLDDTSEALNQLKLASIDEKNWPSDEMPDFPKSDDSKSSSPELVTHLKWDDPYYDIARHQIVEVAGDDKYGRKIIVFSACRMPPSHQLDHSKLLGYLKHTLDQYVESDYTLLYLHHGLTSDNKPSLSWLRDAYREFDRKYKKNIKALYIVHPTMFIKTLLILFKPLISFKFGQKIFYVNYLSELSEHVKLEQLGIPRQVLKYDDFLKSTQKSPATAPKPMPPRPPLPNQQFGVSLQHLQEKNPEQEPIPIVLRETVAYLQAHALTTEGIFRRSANTQVVREVQQKYNMGLPVDFDQYNELHLPAVILKTFLRELPEPLLTFDLYPHVVGFLNIDESQRVPATLQVLQTLPEENYQVLRFLTAFLVQISAHSDQNKMTNTNLAVVFGPNLLWAKDAAITLKAINPINTFTKFLLDHQGELFPSPDPSGL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDPLSELQ -------CCHHHHHC | 12.35 | 22223895 | |
5 | Phosphorylation | ---MDPLSELQDDLT ---CCHHHHHCCCCC | 41.47 | 20873877 | |
12 | Phosphorylation | SELQDDLTLDDTSEA HHHCCCCCCCCHHHH | 34.83 | 28348404 | |
16 | Phosphorylation | DDLTLDDTSEALNQL CCCCCCCHHHHHHHH | 28.29 | 22199227 | |
17 | Phosphorylation | DLTLDDTSEALNQLK CCCCCCHHHHHHHHH | 28.06 | 22199227 | |
27 | Phosphorylation | LNQLKLASIDEKNWP HHHHHHHCCCCCCCC | 40.80 | 29255136 | |
31 | Ubiquitination | KLASIDEKNWPSDEM HHHCCCCCCCCCCCC | 61.64 | 29967540 | |
35 | Phosphorylation | IDEKNWPSDEMPDFP CCCCCCCCCCCCCCC | 37.51 | 22199227 | |
43 | Ubiquitination | DEMPDFPKSDDSKSS CCCCCCCCCCCCCCC | 67.52 | 22817900 | |
44 | Phosphorylation | EMPDFPKSDDSKSSS CCCCCCCCCCCCCCC | 47.06 | 23927012 | |
47 | Phosphorylation | DFPKSDDSKSSSPEL CCCCCCCCCCCCHHH | 39.15 | 25159151 | |
48 | Ubiquitination | FPKSDDSKSSSPELV CCCCCCCCCCCHHHH | 62.44 | 21906983 | |
49 | Phosphorylation | PKSDDSKSSSPELVT CCCCCCCCCCHHHHH | 39.75 | 29255136 | |
50 | Phosphorylation | KSDDSKSSSPELVTH CCCCCCCCCHHHHHH | 54.36 | 29255136 | |
51 | Phosphorylation | SDDSKSSSPELVTHL CCCCCCCCHHHHHHC | 29.50 | 29255136 | |
56 | Phosphorylation | SSSPELVTHLKWDDP CCCHHHHHHCCCCCC | 33.83 | 23927012 | |
56 | O-linked_Glycosylation | SSSPELVTHLKWDDP CCCHHHHHHCCCCCC | 33.83 | OGP | |
59 | Ubiquitination | PELVTHLKWDDPYYD HHHHHHCCCCCCCHH | 40.76 | 29967540 | |
64 | Phosphorylation | HLKWDDPYYDIARHQ HCCCCCCCHHHHHHH | 22.29 | 28152594 | |
65 | Phosphorylation | LKWDDPYYDIARHQI CCCCCCCHHHHHHHE | 13.27 | 28152594 | |
80 | Ubiquitination | VEVAGDDKYGRKIIV EEECCCCCCCCEEEE | 55.11 | 22817900 | |
80 | Acetylation | VEVAGDDKYGRKIIV EEECCCCCCCCEEEE | 55.11 | 19608861 | |
80 | 2-Hydroxyisobutyrylation | VEVAGDDKYGRKIIV EEECCCCCCCCEEEE | 55.11 | - | |
81 | Phosphorylation | EVAGDDKYGRKIIVF EECCCCCCCCEEEEE | 29.20 | - | |
84 | Ubiquitination | GDDKYGRKIIVFSAC CCCCCCCEEEEEEEC | 32.21 | 22817900 | |
89 | Phosphorylation | GRKIIVFSACRMPPS CCEEEEEEECCCCCH | 18.63 | 28857561 | |
93 | Sulfoxidation | IVFSACRMPPSHQLD EEEEECCCCCHHHCC | 6.02 | 30846556 | |
144 | Phosphorylation | LSWLRDAYREFDRKY HHHHHHHHHHHHHHH | 18.24 | - | |
156 | Ubiquitination | RKYKKNIKALYIVHP HHHHHHCCEEEECCH | 41.55 | 33845483 | |
159 | Phosphorylation | KKNIKALYIVHPTMF HHHCCEEEECCHHHH | 13.03 | - | |
168 | Ubiquitination | VHPTMFIKTLLILFK CCHHHHHHHHHHHHH | 23.12 | 21890473 | |
169 | Phosphorylation | HPTMFIKTLLILFKP CHHHHHHHHHHHHHH | 23.21 | 20068231 | |
174 | Ubiquitination | IKTLLILFKPLISFK HHHHHHHHHHHHHHC | 6.41 | 23000965 | |
175 | Ubiquitination | KTLLILFKPLISFKF HHHHHHHHHHHHHCC | 35.15 | 33845483 | |
178 | Ubiquitination | LILFKPLISFKFGQK HHHHHHHHHHCCCCE | 6.54 | 22817900 | |
179 | Phosphorylation | ILFKPLISFKFGQKI HHHHHHHHHCCCCEE | 30.02 | 24719451 | |
212 | Ubiquitination | GIPRQVLKYDDFLKS CCCHHHHCHHHHHHH | 48.02 | 23000965 | |
212 | Acetylation | GIPRQVLKYDDFLKS CCCHHHHCHHHHHHH | 48.02 | 23236377 | |
218 | Methylation | LKYDDFLKSTQKSPA HCHHHHHHHCCCCCC | 51.99 | - | |
218 | Ubiquitination | LKYDDFLKSTQKSPA HCHHHHHHHCCCCCC | 51.99 | 23000965 | |
219 | Phosphorylation | KYDDFLKSTQKSPAT CHHHHHHHCCCCCCC | 37.91 | 26699800 | |
220 | Phosphorylation | YDDFLKSTQKSPATA HHHHHHHCCCCCCCC | 38.13 | 26699800 | |
222 | Ubiquitination | DFLKSTQKSPATAPK HHHHHCCCCCCCCCC | 59.50 | 33845483 | |
223 | Phosphorylation | FLKSTQKSPATAPKP HHHHCCCCCCCCCCC | 15.22 | 26055452 | |
226 | Phosphorylation | STQKSPATAPKPMPP HCCCCCCCCCCCCCC | 47.04 | 30576142 | |
245 | Phosphorylation | PNQQFGVSLQHLQEK CCCCCCCCHHHHHHH | 23.77 | 22115753 | |
284 | Phosphorylation | TEGIFRRSANTQVVR CCCCHHHCCCHHHHH | 22.93 | 28857561 | |
299 | Sulfoxidation | EVQQKYNMGLPVDFD HHHHHHCCCCCCCHH | 5.46 | 30846556 | |
365 | Phosphorylation | QTLPEENYQVLRFLT HHCCHHHHHHHHHHH | 11.86 | - | |
379 | Phosphorylation | TAFLVQISAHSDQNK HHHHHHHHHCCCCCC | 11.66 | 22210691 | |
382 | Phosphorylation | LVQISAHSDQNKMTN HHHHHHCCCCCCCCC | 40.38 | 22210691 | |
388 | Phosphorylation | HSDQNKMTNTNLAVV CCCCCCCCCCCEEEE | 40.27 | 22210691 | |
390 | Phosphorylation | DQNKMTNTNLAVVFG CCCCCCCCCEEEEEC | 23.57 | 24505115 | |
409 | Phosphorylation | WAKDAAITLKAINPI CHHCHHHHHHHCCCC | 19.92 | 22210691 | |
411 | Ubiquitination | KDAAITLKAINPINT HCHHHHHHHCCCCHH | 38.27 | 32015554 | |
420 | Phosphorylation | INPINTFTKFLLDHQ CCCCHHHHHHHHHCC | 20.88 | 24505115 | |
433 | Phosphorylation | HQGELFPSPDPSGL- CCCCCCCCCCCCCC- | 34.30 | 24076635 | |
437 | Phosphorylation | LFPSPDPSGL----- CCCCCCCCCC----- | 61.17 | 27251275 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RHG01_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RHG01_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RHG01_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RHG01_HUMAN | ARHGAP1 | physical | 10954711 | |
BNIP2_HUMAN | BNIP2 | physical | 10954711 | |
RHOA_HUMAN | RHOA | physical | 9548756 | |
RHOA_HUMAN | RHOA | physical | 9407060 | |
CDC42_HUMAN | CDC42 | physical | 9407060 | |
BNIP2_HUMAN | BNIP2 | physical | 10551883 | |
RAC1_HUMAN | RAC1 | physical | 9535855 | |
CDC42_HUMAN | CDC42 | physical | 9535855 | |
RHOA_HUMAN | RHOA | physical | 9535855 | |
RHOA_HUMAN | RHOA | physical | 20660160 | |
CHK2_HUMAN | CHEK2 | physical | 21988832 | |
GFPT1_HUMAN | GFPT1 | physical | 26344197 | |
RUVB2_HUMAN | RUVBL2 | physical | 26344197 | |
CDC42_HUMAN | CDC42 | physical | 14749388 | |
RAC1_HUMAN | RAC1 | physical | 14749388 | |
RHOA_HUMAN | RHOA | physical | 14749388 | |
ATRAP_HUMAN | AGTRAP | physical | 21516116 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-80 AND LYS-212, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND MASSSPECTROMETRY. |